Skip to main content

Table 4 Risks of cardiovascular disease and cancer as causes of death over 12 years according hypnotic use

From: Hypnotics and mortality in an elderly general population: a 12-year prospective study

 

Cardiovascular disease deaths

Cancer deaths

 

No n = 6,311

Yes N = 385

Model 1a

Model 2b

No n = 6,174

Yes N = 522

Model 1a

Model 2b

Variable

n

%

n

%

HR [95% CI]

P

HR [95% CI]

P

n

%

n

%

HR [95% CI]

P

HR [95% CI]

P

Hypnotic use

 No

4,962

78.62

280

72.73

1

0.02

1

0.56

4,818

78.04

424

81.23

1

0.38

1

0.73

 Yes

1,349

21.38

105

27.27

1.32 [1.04;1.66]

 

0.92 [0.71;1.20]

 

1,356

21.96

98

18.77

0.90 [0.72;1.13]

 

0.96 [0.74;1.23]

 

Number of hypnotics

 0

4,962

78.62

280

72.73

1

0.03

1

0.78

4,818

78.04

424

81.23

1

0.67

1

0.94

 1

1,154

18.29

88

22.86

1.26 [0.99;1.61]

 

0.94 [0.72;1.23]

 

1,157

18.74

85

16.28

0.91 [0.72;1.15]

 

0.96 [0.74;1.25]

 

 ≥2

195

3.09

17

4.42

1.69 [1.03;2.76]

 

0.83 [0.45;1.52]

 

199

3.22

13

2.49

0.89 [0.51;1.54]

 

0.93 [0.50;1.72]

 

BZD

 No

5,321

84.31

305

79.22

1

0.004

1

0.60

5,170

83.74

456

87.36

1

0.27

1

0.42

 Yes

990

15.69

80

20.78

1.45 [1.13;1.87]

 

1.08 [0.81;1.43]

 

1,004

16.26

66

12.64

0.86 [0.66;1.12]

 

0.89 [0.66;1.19]

 

BZD-like compounds

 No

6,008

95.20

367

95.32

1

0.65

1

0.12

5,879

95.22

496

95.02

1

0.78

1

0.44

 Yes

303

4.80

18

4.68

0.90 [0.56;1.44]

 

0.67 [0.40;1.11]

 

295

4.78

26

4.98

1.06 [0.71;1.57]

 

1.18 [0.77;1.82]

 

Miscellaneous medications

 No

6,123

97.02

369

95.84

1

0.64

1

0.43

5,986

96.95

506

96.93

1

0.88

1

0.95

 Yes

188

2.98

16

4.16

1.13 [0.68;1.87]

 

0.80 [0.45;1.41]

 

188

3.05

16

3.07

0.96 [0.58;1.59]

 

1.02 [0.59;1.74]

 
  1. aAdjusted for age, study center, and gender; badjusted for all covariates in model 1 plus high level of education, confinement, alcohol intake, smoking status, history of cardio-cerebrovascular disease, respiratory disease, Mini Mental State Examination score, body mass index, hypertension and diabetes mellitus, depressive symptoms, antidepressants use, Spielberger trait anxiety score, excessive daytime sleepiness, and number of insomnia complaints. BZD, benzodiazepines; CI, confidence interval; HR, hazard ratios.